Active substance
Results for the substance lumasiran
1 result
About this active substance
Lumasiran is a medication used for the treatment of primary hyperoxaluria type 1 (PH1), a rare genetic condition that leads to excessive oxalate accumulation in the body. It works by inhibiting oxalate production in the liver.
The medication is administered as a subcutaneous injection, usually once a month for the first three months, then at longer intervals as directed by the doctor.
Side effects may include injection site reactions, fatigue, or abdominal pain. In rare cases, severe allergic reactions may occur.
Lumasiran is not recommended for patients with hypersensitivity to this medication. Monitoring of renal function and oxalate levels is important during treatment.
The medication is administered as a subcutaneous injection, usually once a month for the first three months, then at longer intervals as directed by the doctor.
Side effects may include injection site reactions, fatigue, or abdominal pain. In rare cases, severe allergic reactions may occur.
Lumasiran is not recommended for patients with hypersensitivity to this medication. Monitoring of renal function and oxalate levels is important during treatment.